(RHM) Rheinmetall - Ratings and Ratios
Combat Vehicles, Ammunition, Sensors, Actuators, Air Pumps
RHM EPS (Earnings per Share)
RHM Revenue
Description: RHM Rheinmetall
Rheinmetall AG (XETRA:RHM) is a German-based industrial group that supplies mobility and security technologies across Europe, the Americas, and Asia. It trades as a common stock under the ticker RHM and is classified in the GICS sub-industry “Aerospace & Defense.”
The firm operates through four segments: Vehicle Systems (armored tracked and wheeled vehicles, CBRN protection, artillery and turret systems); Weapon & Ammunition (firearms, ammunition, propellants and protection solutions); Electronic Solutions (sensors, networking platforms, cyber-protection, soldier-system effectors, and training-simulation suites); and Power Systems (automotive and energy-industry components such as e-mobility modules, hydrogen technology, thermal management, bearings and replacement parts). After-market services complement each segment.
Key quantitative signals (FY 2023 figures, subject to revision in the 2024 interim update) show revenue of roughly €6.5 billion, an EBIT margin of 8.2 %, and an order backlog of about €9 billion, indicating strong demand visibility. The company’s R&D spend hovers near 5 % of sales, aligning with the sector’s need to fund digital-warfare and autonomous-vehicle development. A macro driver is the upward trend in European defense budgets-Germany’s FY 2024 defense allocation rose ~5 % YoY, which historically correlates with a 0.6 % lift in Rheinmetall’s revenue per percentage point of budget growth.
If you want a deeper, data-driven view of Rheinmetall’s valuation metrics and scenario analysis, a quick look at the ValueRay platform can provide the analytical tools you need.
RHM Stock Overview
| Market Cap in USD | 99,109m |
| Sub-Industry | Aerospace & Defense |
| IPO / Inception |
RHM Stock Ratings
| Growth Rating | 97.4% |
| Fundamental | 78.2% |
| Dividend Rating | 59.6% |
| Return 12m vs S&P 500 | 223% |
| Analyst Rating | - |
RHM Dividends
| Dividend Yield 12m | 0.46% |
| Yield on Cost 5y | 11.80% |
| Annual Growth 5y | 4.39% |
| Payout Consistency | 90.2% |
| Payout Ratio | 41.5% |
RHM Growth Ratios
| Growth Correlation 3m | 67.7% |
| Growth Correlation 12m | 92.8% |
| Growth Correlation 5y | 97.6% |
| CAGR 5y | 128.48% |
| CAGR/Max DD 3y (Calmar Ratio) | 6.92 |
| CAGR/Mean DD 3y (Pain Ratio) | 25.66 |
| Sharpe Ratio 12m | 2.38 |
| Alpha | 256.76 |
| Beta | 0.565 |
| Volatility | 35.55% |
| Current Volume | 305k |
| Average Volume 20d | 220.9k |
| Stop Loss | 1705.2 (-3.9%) |
| Signal | 0.64 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (822.0m TTM) > 0 and > 6% of Revenue (6% = 640.3m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -2.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.12% (prev 17.28%; Δ -7.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.24b > Net Income 822.0m (YES >=105%, WARN >=100%) |
| Net Debt (-352.0m) to EBITDA (1.89b) ratio: -0.19 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.3m) change vs 12m ago 6.77% (target <= -2.0% for YES) |
| Gross Margin 51.30% (prev 29.73%; Δ 21.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 79.16% (prev 65.75%; Δ 13.41pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.02 (EBITDA TTM 1.89b / Interest Expense TTM 130.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.19
| (A) 0.07 = (Total Current Assets 8.38b - Total Current Liabilities 7.29b) / Total Assets 14.59b |
| (B) 0.20 = Retained Earnings (Balance) 2.98b / Total Assets 14.59b |
| (C) 0.11 = EBIT TTM 1.43b / Avg Total Assets 13.48b |
| (D) 0.31 = Book Value of Equity 3.03b / Total Liabilities 9.68b |
| Total Rating: 2.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.21
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 0.44% = 0.22 |
| 3. FCF Margin 3.61% = 0.90 |
| 4. Debt/Equity 0.45 = 2.40 |
| 5. Debt/Ebitda -0.19 = 2.50 |
| 6. ROIC - WACC (= 15.67)% = 12.50 |
| 7. RoE 20.14% = 1.68 |
| 8. Rev. Trend 66.05% = 4.95 |
| 9. EPS Trend 21.07% = 1.05 |
What is the price of RHM shares?
Over the past week, the price has changed by -6.80%, over one month by -6.65%, over three months by -2.34% and over the past year by +270.63%.
Is Rheinmetall a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RHM is around 2387.67 EUR . This means that RHM is currently undervalued and has a potential upside of +34.55% (Margin of Safety).
Is RHM a buy, sell or hold?
What are the forecasts/targets for the RHM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2161.6 | 21.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2648.6 | 49.3% |
RHM Fundamental Data Overview
Market Cap EUR = 84.96b (84.96b EUR * 1.0 EUR.EUR)
P/E Trailing = 102.0364
P/E Forward = 50.5051
P/S = 7.962
P/B = 19.6573
P/EG = 1.164
Beta = 0.565
Revenue TTM = 10.67b EUR
EBIT TTM = 1.43b EUR
EBITDA TTM = 1.89b EUR
Long Term Debt = 1.60b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 791.0m EUR (from shortTermDebt, last quarter)
Debt = 2.01b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -352.0m EUR (from netDebt column, last quarter)
Enterprise Value = 86.62b EUR (84.96b + Debt 2.01b - CCE 352.0m)
Interest Coverage Ratio = 11.02 (Ebit TTM 1.43b / Interest Expense TTM 130.0m)
FCF Yield = 0.44% (FCF TTM 385.0m / Enterprise Value 86.62b)
FCF Margin = 3.61% (FCF TTM 385.0m / Revenue TTM 10.67b)
Net Margin = 7.70% (Net Income TTM 822.0m / Revenue TTM 10.67b)
Gross Margin = 51.30% ((Revenue TTM 10.67b - Cost of Revenue TTM 5.20b) / Revenue TTM)
Gross Margin QoQ = 53.42% (prev 53.71%)
Tobins Q-Ratio = 5.94 (Enterprise Value 86.62b / Total Assets 14.59b)
Interest Expense / Debt = 1.00% (Interest Expense 20.0m / Debt 2.01b)
Taxrate = 24.09% (53.0m / 220.0m)
NOPAT = 1.09b (EBIT 1.43b * (1 - 24.09%))
Current Ratio = 1.15 (Total Current Assets 8.38b / Total Current Liabilities 7.29b)
Debt / Equity = 0.45 (Debt 2.01b / totalStockholderEquity, last quarter 4.46b)
Debt / EBITDA = -0.19 (Net Debt -352.0m / EBITDA 1.89b)
Debt / FCF = -0.91 (Net Debt -352.0m / FCF TTM 385.0m)
Total Stockholder Equity = 4.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.63% (Net Income 822.0m / Total Assets 14.59b)
RoE = 20.14% (Net Income TTM 822.0m / Total Stockholder Equity 4.08b)
RoCE = 25.22% (EBIT 1.43b / Capital Employed (Equity 4.08b + L.T.Debt 1.60b))
RoIC = 23.60% (NOPAT 1.09b / Invested Capital 4.61b)
WACC = 7.93% (E(84.96b)/V(86.97b) * Re(8.10%) + D(2.01b)/V(86.97b) * Rd(1.00%) * (1-Tc(0.24)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF Debug] Terminal Value 78.83% ; FCFE base≈495.4m ; Y1≈520.9m ; Y5≈611.1m
Fair Price DCF = 237.7 (DCF Value 10.61b / Shares Outstanding 44.6m; 5y FCF grow 5.59% → 3.0% )
EPS Correlation: 21.07 | EPS CAGR: 33.68% | SUE: -0.33 | # QB: 0
Revenue Correlation: 66.05 | Revenue CAGR: 21.73% | SUE: -0.55 | # QB: 0